PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils
Acute lung injury (ALI) can cause acute respiratory distress syndrome (ARDS), a lethal condition with limited treatment options and currently a common global cause of death due to COVID-19. ARDS secondary to transfusion-related ALI (TRALI) has been recapitulated preclinically by anti–MHC-I antibody...
Main Authors: | Dongyan Song, Jose M. Adrover, Christy Felice, Lisa N. Christensen, Xue-Yan He, Joseph R. Merrill, John E. Wilkinson, Tobias Janowitz, Scott K. Lyons, Mikala Egeblad, Nicholas K. Tonks |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-07-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.158199 |
Similar Items
-
Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
by: Andrew G. Weber, et al.
Published: (2020-09-01) -
Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection
by: Jose M. Adrover, et al.
Published: (2022-03-01) -
Vanadium Compounds as PTP Inhibitors
by: Elsa Irving, et al.
Published: (2017-12-01) -
Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development
by: Navasona Krishnan, et al.
Published: (2018-01-01) -
Caught in the act: revealing the metastatic process by live imaging
by: Miriam R. Fein, et al.
Published: (2013-05-01)